[Advanced ovarian cancer: primary debulking (PDS) or neoadjuvant chemotherapy (NACT) - still a debate]

Yakir Segev, Ofer Gemer, Ron Auslender, Ofer Lavie

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of '[Advanced ovarian cancer: primary debulking (PDS) or neoadjuvant chemotherapy (NACT) - still a debate]'. Together they form a unique fingerprint.

Medicine & Life Sciences